Contemporary management of silent ischemia: The role of ambulatory monitoring

International Journal of Cardiology

Volumn 96, Issue 3, 2004, Pages 311-319

  Solomon, Hemant ^a,b   DeBusk, Robert F ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b MAYO CLINIC ROCHESTER   (United States)

Author keywords

Ambulatory electrocardiographic monitoring; Cardiovascular risk; Silent ischemia

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANTITHROMBOCYTIC AGENT; ATENOLOL PLUS NIFEDIPINE; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOSORBIDE DINITRATE; NIFEDIPINE; NITRATE; PRAVASTATIN; QUINAPRIL; SIMVASTATIN;

AMBULATORY MONITORING; CARDIOVASCULAR RISK; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG EFFICACY; ELECTROCARDIOGRAPHY MONITORING; FOLLOW UP; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SILENT MYOCARDIAL ISCHEMIA; STABLE ANGINA PECTORIS; SURVIVAL; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

ELECTROCARDIOGRAPHY, AMBULATORY; EXERCISE TEST; HUMANS; MYOCARDIAL ISCHEMIA; PROGNOSIS;

EID: 4143128926     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.08.019     Document Type: Review

References (52)

1. Gottlieb S.O., Weisfeldt M.L., Ouyang P., Mellits E.D., Gerstenblith G. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N. Engl. J. Med. 314:1986;1214-1219
2. Colbeck E. Angina pectoris: a criticism and a hypothesis. Lancet. i:1903;793-795
3. Deedwania P.C., Carbajal E.V. Silent myocardial ischemia. A clinical perspective. Arch. Intern. Med. 151:1991;2373-2382
4. Panza J.A., Diodati J.G., Callahan T.S., Epstein S.E., Quyyumi A.A. Role of increases in heart rate in determining the occurrence and frequency of myocardial ischemia during daily life in patients with stable coronary artery disease. J. Am. Coll. Cardiol. 20:1992;1092-1098
5. Hinderliter A., Miller P., Bragdon E., Ballenger M., Sheps D. Myocardial ischemia during daily activities: the importance of increased myocardial oxygen demand. J. Am. Coll. Cardiol. 18:1991;405-412
6. Imperi G.A., Lambert C.R., Coy K., Lopez L., Pepine C.J. Effects of titrated beta blockade (metoprolol) on silent myocardial ischemia in ambulatory patients with coronary artery disease. Am. J. Cardiol. 60:1987;519-524
7. Krittayaphong R., Biles P.L., Christy C.G., Sheps D.S. Association between angina pectoris and ischemic indexes during exercise testing and ambulatory monitoring. Am. J. Cardiol. 78:1996;266-270
8. Deedwania P.C., Nelson J.R. Pathophysiology of silent myocardial ischemia during daily life. Hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring. Circulation. 82:1990;1296-1304
9. Andrews T.C., Fenton T., Toyosaki N., et al. Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS). Circulation. 88:1993;92-100
10. Kathiresan S, Jordan MK, Gimelli G, Lopez-Cuellar J, Madhi N, Jang IK. Frequency of silent myocardial ischemia following coronary stenting. Am J Cardiol 1999; 84:930-2, A7.
11. Gage J.E., Hess O.M., Murakami T., Ritter M., Grimm J., Krayenbuehl H.P. Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin. Circulation. 73:1986;865-876
12. Mudge G.H. Jr., Grossman W., Mills R.M. Jr., Lesch M., Braunwald E. Reflex increase in coronary vascular resistance in patients with ischemic heart disease. N. Engl. J. Med. 295:1976;1333-1337
13. Ludmer P.L., Selwyn A.P., Shook T.L., et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N. Engl. J. Med. 315:1986;1046-1051
14. Verrier R.L., Hagestad E.L., Lown B. Delayed myocardial ischemia induced by anger. Circulation. 75:1987;249-254
15. Yeung A.C., Vekshtein V.I., Krantz D.S., et al. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N. Engl. J. Med. 325:1991;1551-1556
16. Stern S., Tzivoni D. Early detection of silent ischaemic heart disease by 24-hour electrocardiographic monitoring of active subjects. Br. Heart J. 36:1974;481-486
17. Norgaard B.L., Andersen K., Dellborg M., Abrahamsson P., Ravkilde J., Thygesen K. Admission risk assessment by cardiac troponin T in unstable coronary artery disease: additional prognostic information from continuous ST segment monitoring. TRIM study group. Thrombin Inhibition in Myocardial Ischemia. J. Am. Coll. Cardiol. 33:1999;1519-1527
18. Akkerhuis K.M., Klootwijk P.A., Lindeboom W., et al. Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events; meta-analysis of three studies involving 995 patients. Eur. Heart J. 22:2001;1997-2006
19. Gill J.B., Cairns J.A., Roberts R.S., et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring early after acute myocardial infarction. N. Engl. J. Med. 334:1996;65-70
20. Bogaty P., Dumont S., O'Hara G.E., et al. Randomized trial of a noninvasive strategy to reduce hospital stay for patients with low-risk myocardial infarction. J. Am. Coll. Cardiol. 37:2001;1289-1296
21. Hamm C.W., Goldmann B.U., Heeschen C., Kreymann G., Berger J., Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N. Engl. J. Med. 337:1997;1648-1653
22. Deedwania P.C., Stone P.H. Ambulatory electrocardiographic monitoring for myocardial ischemia. Curr. Probl. Cardiol. 26:2001;680-727
23. Rocco M.B., Nabel E.G., Campbell S., et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with stable coronary artery disease. Circulation. 78:1988;877-884
24. Forslund L., Hjemdahl P., Held C., Eriksson S.V., Bjorkander I., Rehnqvist N. Prognostic implications of ambulatory myocardial ischemia and arrhythmias and relations to ischemia on exercise in chronic stable angina pectoris (the Angina Prognosis Study in Stockholm [APSIS]). Am. J. Cardiol. 84:1999;1151-1157
25. Deedwania P.C., Carbajal E.V. Usefulness of ambulatory silent myocardial ischemia added to the prognostic value of exercise test parameters in predicting risk of cardiac death in patients with stable angina pectoris and exercise-induced myocardial ischemia. Am. J. Cardiol. 68:1991;1279-1286
26. Goodman S.G., Freeman M.R., Armstrong P.W., Langer A. Does ambulatory monitoring contribute to exercise testing and myocardial perfusion scintigraphy in the prediction of the extent of coronary artery disease in stable angina? Am. J. Cardiol. 73:1994;747-752
27. Nair C.K., Khan I.A., Esterbrooks D.J., Ryschon K.L., Hilleman D.E. Diagnostic and prognostic value of Holter-detected ST-segment deviation in unselected patients with chest pain referred for coronary angiography: a long-term follow-up analysis. Chest. 120:2001;834-839
28. Boon D., Piek J.J., van Montfrans G.A. Silent ischaemia and hypertension. J. Hypertens. 18:2000;1355-1364
29. Davies R.F., Goldberg A.D., Forman S., et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation. 95:1997;2037-2043
30. Knatterud G.L., Bourassa M.G., Pepine C.J., et al. Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study. J. Am. Coll. Cardiol. 24:1994;11-20
31. Stone P.H., Chaitman B.R., Forman S., et al. Prognostic significance of myocardial ischemia detected by ambulatory electrocardiography, exercise treadmill testing, and electrocardiogram at rest to predict cardiac events by one year (the Asymptomatic Cardiac Ischemia Pilot [ACIP] study). Am. J. Cardiol. 80:1997;1395-1401
32. Killip T. Silent myocardial ischemia: some good news. Circulation. 95:1997;1992-1993
33. Pepine C.J., Cohn P.F., Deedwania P.C., et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST). Circulation. 90:1994;762-768
34. Von Arnim T. Prognostic significance of transient ischemic episodes: response to treatment shows improved prognosis. Results of the Total Ischemic Burden Bisoprolol Study (TIBBs) follow-up. J. Am. Coll. Cardiol. 28:1996;20-24
35. Madjlessi-Simon T., Mary-Krause M., Fillette F., Lechat P., Jaillon P. Persistent transient myocardial ischemia despite beta-adrenergic blockade predicts a higher risk of adverse cardiac events in patients with coronary artery disease. J. Am. Coll. Cardiol. 27:1996;1586-1591
36. Fox K.M., Mulcahy D., Findlay I., Ford I., Dargie H.J. The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group. Eur. Heart J. 17:1996;96-103
37. Shepherd J., Cobbe S.M., Ford I., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N. Engl. J. Med. 333:1995;1301-1307
38. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 344:1994;1383-1389
39. van Boven A.J., Jukema J.W., Zwinderman A.H., Crijns H.J., Lie K.I., Bruschke A.V. Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group. Circulation. 94:1996;1503-1505
40. Walter D.H., Rittig K., Bahlmann F.H., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation. 105:2002;3017-3024
41. Liem A.H., van Boven A.J., Veeger N.J., et al. Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial. Eur. Heart J. 23:2002;1931-1937
42. Heart Protection Study Collaborative MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 360:2002;7-22
43. The effects of pravastatin on hospital admission in hypercholesterolemic middle-aged men: west of Scotland Coronary Prevention Study. J. Am. Coll. Cardiol. 33:1999;909-915
44. Tzivoni D., Gottlieb S., Khurmi N.S., Medina A., Gavish A., Stern S. Effect of benazepril on myocardial ischaemia in patients with chronic stable angina pectoris. Eur. Heart J. 13:1992;1129-1134
45. Oosterga M., Voors A.A., Pinto Y.M., et al. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). Quinapril on Vascular Ace and Determinants of Ischemia. Am. J. Cardiol. 87:2001;542-546
46. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N. Engl. J. Med. 327:1992;669-677
47. Kleinert S. HOPE for cardiovascular disease prevention with ACE-inhibitor ramipril. Heart Outcomes Prevention Evaluation. Lancet. 354:1999;841
48. Schlaifer J.D., Wargovich T.J., O'Neill B., et al. Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction. Am. J. Cardiol. 80:1997;1594-1597
49. Frishman W.H., Glasser S., Stone P., Deedwania P.C., Johnson M., Fakouhi T.D. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris. Am. J. Cardiol. 83:1999;507-514
50. Deanfield J., Detry J., Sellier P., et al. Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial. J. Am. Coll. Cardiol. 40:2002;917
51. Mahony C. Effect of aspirin on myocardial ischemia. Am. J. Cardiol. 64:1989;387-389
52. Mason R.P. Mechanisms of plaque stabilization for the dihydropyridine calcium channel blocker amlodipine: review of the evidence. Atherosclerosis. 165:2002;191-199